UK markets open in 5 hours 2 minutes
  • NIKKEI 225

    26,154.01
    -269.46 (-1.02%)
     
  • HANG SENG

    21,699.26
    -153.81 (-0.70%)
     
  • CRUDE OIL

    100.69
    +1.19 (+1.20%)
     
  • GOLD FUTURES

    1,768.80
    +4.90 (+0.28%)
     
  • DOW

    30,967.82
    -129.44 (-0.42%)
     
  • BTC-GBP

    16,622.64
    -403.89 (-2.37%)
     
  • CMC Crypto 200

    430.74
    -9.28 (-2.11%)
     
  • ^IXIC

    11,322.24
    +194.39 (+1.75%)
     
  • ^FTAS

    3,863.91
    -103.70 (-2.61%)
     

Global Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Analysis

·9-min read
Company Logo
Company Logo

Global Synthetic Biology Market

Global Synthetic Biology Market
Global Synthetic Biology Market

Dublin, June 02, 2022 (GLOBE NEWSWIRE) -- The "Global Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Products, Technology, and Application" report has been added to ResearchAndMarkets.com's offering.

The global synthetic biology market is expected to grow from US$ 10,544.16 million in 2021 to US$ 37,850.85 million by 2028; it is estimated to grow at a CAGR of 20.0% from 2021 to 2028. The report highlights trends prevailing in the synthetic biology market and factors driving its growth. The increasing investments in synthetic biology and the rising number of start-ups are driving the market growth. However, the renewed regulations for biotechnology hamper the market growth.

Synthetic biology is the science of designing, altering, and building simple organisms to perform specific therapeutic or industrial utilities. The organisms created are genetically modified organisms (GMOs), which do not require a definition that distinguishes them from genetic modifications.

The rising number of start-ups is expected to support market growth during the forecast period. Biotechnology entrepreneurs easily raise funds and procure equipment and space from governments of the respective countries. Indie Bio (California, US) and EU (Ireland) are among the first synthetic biology accelerators. The start-ups are emerging in Asia Pacific, as governments in this region are providing funds for the domestic development of synthetic biology.

For instance, the Government of India funded IITM Bioincubator, a department of the Indian Institute of Technology Madras, to start a state-of-the-art research facility for cancer biology and a Bioinformatics Infrastructure Facility. The funds were provided by agencies such as the Council of Scientific and Industrial Research (CSIR), the Department of Biotechnology (DBT), and the Department of Science and Technology (DST).

The Indian Institute of Technology Madras raised US$ 7.86 million (550 million rupees) in the fiscal year 2016-2017. In China, Chinaccelerator is a financer that provides mentorship programs for helping start-ups. It is also associated with SOSV, a venture capital and investment management firm,, which helps establish start-ups by providing funds under programs such as RebelBio and Indie Bio. The easy availability of funds for ideas is motivating entrepreneurs in the world to establish synthetic biology businesses.

Based on product, the synthetic biology market is segmented into oligonucleotides, chassis organisms, enzymes, and xeno-nucleic acid. The oligonucleotides segment is likely to hold the largest share of the market in 2021. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period of 2021 to 2028. Based on technology, the synthetic biology market is segmented into, gene synthesis, genome engineering, measurement & modeling, cloning & sequencing, nanotechnology, and others. In 2021, the gene synthesis segment is likely to hold the largest share of the market. However, the genome engineering segment is expected to register highest CAGR during 2021 to 2028. The growth of genome engineering segment is owing to the rising applications of genetic engineering and gene therapy.

Further, based on application, the synthetic biology market is segmented into medical applications, industrial applications, environmental applications, food and agriculture, and others. The medical applications segment is further segmented as, drug discovery & therapeutics and pharmaceuticals. In 2021, the medical applications segment held the largest market share, and it is expected to register the highest CAGR during 2021-2028.

Various organic and inorganic strategies are adopted by companies operating in the synthetic biology market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies have allowed the synthetic biology market players in expanding their business and enhancing their geographic presence, along with contributing to the overall market growth. Additionally, growth strategies such as acquisitions and partnerships helped them strengthen their customer base and extend their product portfolios.

Key Topics Covered:

1. Introduction

2. Key Takeaways

3. Research Methodology

4. Synthetic Biology Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Experts Opinion

5. Synthetic Biology Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Investments in Synthetic Biology
5.1.2 Rising Number of Start-Ups
5.2 Key Market Restraints
5.2.1 Renewed Regulations for Biotechnology
5.3 Key Market Opportunities
5.3.1 Collaboration Between Companies
5.4 Future Trends
5.4.1 Advanced Synthetic Biology
5.5 Impact Analysis

6. Synthetic Biology Market - Global Analysis
6.1 Global Synthetic Biology Market Revenue Forecast and Analysis
6.1.1 Global Synthetic Biology Market Revenue Forecast and Analysis
6.1.2 Global Synthetic Biology Market - Market Potential Analysis, By Region
6.2 Company Analysis
6.2.1 Market Positioning of Key Players
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance of Key Players
6.2.4.1 Thermo Fisher Scientific
6.2.4.2 Twist Bioscience
6.2.4.3 Agilent Technologies, Inc.

7. Synthetic Biology Market Analysis - By Product
7.1 Overview
7.2 Synthetic Biology Market, By Product, 2021 & 2028 (%)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzyme: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Oligonucleotides
7.4.1 Overview
7.4.2 Oligonucleotide: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Chassis Organisms
7.5.1 Overview
7.5.2 Chassis Organisms: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Xeno-Nucleic Acids
7.6.1 Overview
7.6.2 Xeno-Nucleic Acids: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

8. Synthetic Biology Market Analysis - By Technology
8.1 Overview
8.2 Synthetic Biology Market Share by Technology - 2021 & 2028 (%)
8.3 Gene Synthesis
8.3.1 Overview
8.3.2 Gene Synthesis: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.4 Genome Engineering
8.4.1 Overview
8.4.2 Genome Engineering: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.5 Measurement and Modeling
8.5.1 Overview
8.5.2 Measurement and Modeling: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.6 Cloning and Sequencing
8.6.1 Overview
8.6.2 Cloning and Sequencing: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.7 Nanotechnology
8.7.1 Overview
8.7.2 Nanotechnology: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9. Synthetic Biology Market Analysis - By Application
9.1 Overview
9.2 Synthetic Biology Market Share by Application - 2021 & 2028 (%)
9.3 Medical Applications
9.3.1 Overview
9.3.2 Medical Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.3.2.1 Drug Discovery and Therapeutics
9.3.2.1.1 Overview
9.3.2.1.2 Drug Discovery and Therapeutics: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.3.2.2 Pharmaceuticals
9.3.2.2.1 Overview
9.3.2.2.2 Pharmaceuticals: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.4 Industrial Applications
9.4.1 Overview
9.4.2 Industrial Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.5 Food & Agriculture
9.5.1 Overview
9.5.2 Food & Agriculture: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.6 Environmental Applications
9.6.1 Overview
9.6.2 Environmental Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

10. Global Synthetic Biology Market - Geographic Analysis

11. Impact Of COVID-19 Pandemic on Synthetic Biology Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Synthetic Biology Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Synthetic Biology Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Agilent Technologies, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MERCK KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 New England Biolabs
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Integrated DNA Technologies
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Twist Bioscience
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GenScript Biotech Corporation
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Novozymes A/S
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Codexis
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Amyris Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/7uqpur

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting